vs
Circle Internet Group, Inc.（CRCL）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是Circle Internet Group, Inc.的1.9倍（$1.4B vs $739.8M），Circle Internet Group, Inc.净利率更高（29.0% vs 27.6%，领先1.4%），Circle Internet Group, Inc.同比增速更快（5113.5% vs 11.0%），瑞思迈自由现金流更多（$311.2M vs $-14.7M）
Circle是2013年由杰里米·阿莱尔与肖恩·内维尔联合创立的支付科技企业，目前总部位于美国纽约，核心业务覆盖稳定币发行，推出了锚定美元的USDC、锚定欧元的EURC两款稳定币，同时还发行有代币化货币市场基金产品USYC。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CRCL vs RMD — 直观对比
营收规模更大
RMD
是对方的1.9倍
$739.8M
营收增速更快
CRCL
高出5102.6%
11.0%
净利率更高
CRCL
高出1.4%
27.6%
自由现金流更多
RMD
多$325.9M
$-14.7M
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $739.8M | $1.4B |
| 净利润 | $214.4M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 11.0% | 34.6% |
| 净利率 | 29.0% | 27.6% |
| 营收同比 | 5113.5% | 11.0% |
| 净利润同比 | 202.0% | 13.9% |
| 每股收益（稀释后） | $0.64 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRCLRMD
| Q4 25 | — | $1.4B | ||
| Q3 25 | $739.8M | $1.3B | ||
| Q2 25 | $658.1M | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $6.8M | $1.2B | ||
| Q1 24 | — | $1.2B |
净利润CRCLRMD
| Q4 25 | — | $392.6M | ||
| Q3 25 | $214.4M | $348.5M | ||
| Q2 25 | $-482.1M | $379.7M | ||
| Q1 25 | — | $365.0M | ||
| Q4 24 | — | $344.6M | ||
| Q3 24 | — | $311.4M | ||
| Q2 24 | $32.9M | $292.2M | ||
| Q1 24 | — | $300.5M |
毛利率CRCLRMD
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率CRCLRMD
| Q4 25 | — | 34.6% | ||
| Q3 25 | 11.0% | 33.4% | ||
| Q2 25 | -49.5% | 33.7% | ||
| Q1 25 | — | 33.0% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | — | 31.6% | ||
| Q2 24 | — | 31.2% | ||
| Q1 24 | — | 31.3% |
净利率CRCLRMD
| Q4 25 | — | 27.6% | ||
| Q3 25 | 29.0% | 26.1% | ||
| Q2 25 | -73.3% | 28.2% | ||
| Q1 25 | — | 28.3% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | 486.5% | 23.9% | ||
| Q1 24 | — | 25.1% |
每股收益（稀释后）CRCLRMD
| Q4 25 | — | $2.68 | ||
| Q3 25 | $0.64 | $2.37 | ||
| Q2 25 | $-4.48 | $2.58 | ||
| Q1 25 | — | $2.48 | ||
| Q4 24 | — | $2.34 | ||
| Q3 24 | — | $2.11 | ||
| Q2 24 | $0.00 | $1.97 | ||
| Q1 24 | — | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.3B | $1.4B |
| 总债务越低越好 | — | $403.9M |
| 股东权益账面价值 | $3.0B | $6.3B |
| 总资产 | $76.8B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资CRCLRMD
| Q4 25 | — | $1.4B | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.1B | $1.2B | ||
| Q1 25 | — | $932.7M | ||
| Q4 24 | — | $521.9M | ||
| Q3 24 | — | $426.4M | ||
| Q2 24 | $457.5M | $238.4M | ||
| Q1 24 | — | $237.9M |
总债务CRCLRMD
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益CRCLRMD
| Q4 25 | — | $6.3B | ||
| Q3 25 | $3.0B | $6.1B | ||
| Q2 25 | $2.4B | $6.0B | ||
| Q1 25 | — | $5.5B | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | — | $5.2B | ||
| Q2 24 | $460.9M | $4.9B | ||
| Q1 24 | — | $4.6B |
总资产CRCLRMD
| Q4 25 | — | $8.5B | ||
| Q3 25 | $76.8B | $8.3B | ||
| Q2 25 | $64.2B | $8.2B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.1B | ||
| Q3 24 | — | $7.2B | ||
| Q2 24 | — | $6.9B | ||
| Q1 24 | — | $6.8B |
负债/权益比CRCLRMD
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.7M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $-14.7M | $311.2M |
| 自由现金流率自由现金流/营收 | -2.0% | 21.9% |
| 资本支出强度资本支出/营收 | 0.5% | 2.0% |
| 现金转化率经营现金流/净利润 | -0.05× | 0.87× |
| 过去12个月自由现金流最近4个季度 | — | $1.8B |
8季度趋势，按日历期对齐
经营现金流CRCLRMD
| Q4 25 | — | $339.7M | ||
| Q3 25 | $-10.7M | $457.3M | ||
| Q2 25 | $303.7M | $538.8M | ||
| Q1 25 | — | $578.7M | ||
| Q4 24 | — | $308.6M | ||
| Q3 24 | — | $325.5M | ||
| Q2 24 | — | $440.1M | ||
| Q1 24 | — | $402.0M |
自由现金流CRCLRMD
| Q4 25 | — | $311.2M | ||
| Q3 25 | $-14.7M | $414.4M | ||
| Q2 25 | $296.3M | $508.2M | ||
| Q1 25 | — | $557.9M | ||
| Q4 24 | — | $288.0M | ||
| Q3 24 | — | $307.7M | ||
| Q2 24 | — | $415.2M | ||
| Q1 24 | — | $380.8M |
自由现金流率CRCLRMD
| Q4 25 | — | 21.9% | ||
| Q3 25 | -2.0% | 31.0% | ||
| Q2 25 | 45.0% | 37.7% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | — | 25.1% | ||
| Q2 24 | — | 33.9% | ||
| Q1 24 | — | 31.8% |
资本支出强度CRCLRMD
| Q4 25 | — | 2.0% | ||
| Q3 25 | 0.5% | 3.2% | ||
| Q2 25 | 1.1% | 2.3% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 1.8% |
现金转化率CRCLRMD
| Q4 25 | — | 0.87× | ||
| Q3 25 | -0.05× | 1.31× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | 1.05× | ||
| Q2 24 | — | 1.51× | ||
| Q1 24 | — | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRCL
暂无分部数据
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
